PALO ALTO, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) —, a trailblazing healthtech startup hailing from the Stanford University campus, announced today that it has raised $8M in seed funding to launch an end-to-end solution for early stage clinical research. The oversubscribed round was led by General Catalyst with participation from Maven Ventures, the Ovo Fund, NV investments (led by Vivi Nivo), Ken Frazier (former Chairman and CEO of Merck), Dr. Linda Grais (former biotech founder and CEO), and others. To date, Medeloop has raised $10M in a year that will ensure continued expansion, key hires, and technological innovation.

Read more here.